Hi Welcome You can highlight texts in any article and it becomes audio news that you can hear
  • Sun. Oct 6th, 2024

EMA Panel Backs Xofluza for Influenza, Post-Exposure Prophylaxis

Byindianadmin

Nov 18, 2020

Xofluza (baloxavir marboxil) cuts the duration of influenza-related signs and lowers infections when given as post-exposure prophylaxis. International Approvals
Learn More

Click to listen highlighted text!